Top

Cancer Causes & Control

Published in:

01-02-2022 | Kidney Cancer | Original Paper

Kidney cancer trends and risk factors in Lebanon: a 12-year epidemiological study

Authors: Elise Assouad, Said El Hage, Steven Safi, Antonio El Kareh, Elie Mokled, Pascale Salameh

Published in: Cancer Causes & Control | Issue 2/2022

Abstract

Purpose

Lebanon has witnessed an increase in the rates of several cancer subtypes over the last years. The aim of this study is to examine the incidence rates of kidney cancer in Lebanon over 12 years and to compare them to other countries.

Methods

Data were collected from the Lebanese National Cancer Registry (NCR) for the time period 2005–2016 (inclusive). Data from other countries were retrieved from an online database “Cancer Incidence in Five Continents.” The age specific and age-standardized rates (ASR) were calculated and analyzed using Joinpoint regression.

Results

Kidney cancer ranked as the 10th commonest cancer among men and the 19th among women. An age-standardized rate of 3.54 (per 100,000) was obtained. The average ASR was 4.80 for men and 2.27 for women. Kidney cancer showed a significantly rising trend for both genders. Lebanon had the highest ASR for kidney cancer in men and the third highest in women among regional countries.

Conclusion

Lebanon presented an average-to-high ASR for kidney cancer compared to regional countries. However, compared to countries worldwide, Lebanon had a below-average ASR. Nonetheless, with the rising kidney cancer trends, it is important to study the associated risk factors in order to develop proper preventive and screening measures and therefore decrease the incidence rates.

Owens B (2016) Kidney cancer. Nature. https://doi.org/10.1038/537S97aCrossRefPubMed

Johansson ME, Axelson H (2013) Kidney cancer. Semin Cancer Biol 23(1):1–2. https://doi.org/10.1016/j.semcancer.2012.05.006CrossRefPubMed

Turajlic S, Swanton C, Boshoff C (2018) Kidney cancer: the next decade. J Exp Med 215(10):2477–2479. https://doi.org/10.1084/jem.20181617CrossRefPubMedPubMedCentral

Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353(23):2477–2490. https://doi.org/10.1056/NEJMra043172CrossRefPubMed

Chow WH, Gridley G, Fraumeni JF, Järvholm B (2000) Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343(18):1305–1311. https://doi.org/10.1056/NEJM200011023431804CrossRefPubMed

Wilson KM, Cho E (2016) Obesity and kidney cancer. Recent Results Cancer Res 208:81–93. https://doi.org/10.1007/978-3-319-42542-9_5CrossRefPubMed

Liu X et al (2019) Dose-response relationships between cigarette smoking and kidney cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 142:86–93. https://doi.org/10.1016/j.critrevonc.2019.07.019CrossRefPubMed

Ball MW, Shuch BM (2019) Inherited kidney cancer syndromes. Curr Opin Urol 29(4):334–343. https://doi.org/10.1097/MOU.0000000000000646CrossRefPubMed

Jemal A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55(1):10–30. https://doi.org/10.3322/canjclin.55.1.10CrossRefPubMed

10.

Marenčák J, Ondrušová M, Ondruš D (2017) Recent overview of kidney cancer diagnostics and treatment. Klin Onkol Cas Ceske Slov Onkol Spolecnosti 30(3):175–181. https://doi.org/10.14735/amko2017175CrossRef

11.

Powles T, ESMO Guidelines Committee (2021) Electronic address: clinicalguidelines@esmo.org. Recent eUpdate to the ESMO Clinical Practice Guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer: renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(3):422–423. https://doi.org/10.1016/j.annonc.2020.11.016

12.

“United Nations. World Statistics Pocketbook [Lebanon].” http://data.un.org/CountryProfile.aspx/_Images/_Docs/CountryProfile.aspx?crName=Lebanon. Accessed 09 Aug 2020

13.

“Ministry of Public Health. National Cancer Registry (NCR) of Lebanon.” http://www.moph.gov.lb. Accessed 09 Aug 2020

14.

“World Population Prospects—Population Division—United Nations.” https://population.un.org/wpp/. Accessed 15 June 2020

15.

Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M (n.d.) Age standardization of rates: a new WHO standard, p 14

16.

Segi M, Kyokai NT, Igakubu TD (2020) “Cancer mortality for selected sites in 24 countries.” Nagoya, Japan [etc.]: Japan Cancer Society [etc.], 1950, [Online]. Available: https://trove.nla.gov.au/version/14545131. Accessed 15 June 2020

17.

Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-zCrossRefPubMed

18.

“Sample Joinpoint Analyses.” https://surveillance.cancer.gov/joinpoint/analyses.html. Accessed 15 June 2020

19.

“Generate Random Countries.” https://www.randomlists.com/random-country. Accessed 15 June 2020

20.

Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R, Ferlay J. Cancer incidence in five continents, vol XI

21.

Dyba T, Hakulinen T (2000) Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 19(13):1741–1752. https://doi.org/10.1002/1097-0258(20000715)19:13%3c1741::aid-sim496%3e3.0.co;2-oCrossRefPubMed

22.

O’Lorcain P, Deady S, Comber H (2006) Mortality predictions for colon and anorectal cancer for Ireland, 2003–17. Colorectal Dis 8(5):393–401. https://doi.org/10.1111/j.1463-1318.2006.00951.xCrossRefPubMed

23.

Haddad FG, Kattan J, Kourie HR, El Rassy E, Assi T, Adib SM (2018) Geriatric cancer trends in the Middle-East: findings from Lebanese cancer projections until 2025. J Geriatr Oncol 9(2):120–123. https://doi.org/10.1016/j.jgo.2017.08.006CrossRefPubMed

24.

Khafaja S, Kourie HR, Matar D, Sader-Ghorra C, Kattan J (2015) Kidney cancer in Lebanon: a specific histological distribution? Asian Pac J Cancer Prev 16(1):363–365. https://doi.org/10.7314/APJCP.2015.16.1.363CrossRefPubMed

25.

Alkhateeb SS, Alothman AS, Addar AM, Alqahtani RA, Mansi TM, Masuadi EM (2018) Kidney cancer in Saudi Arabia. A 25-year analysis of epidemiology and risk factors in a tertiary center. Saudi Med J 39(5):459–463. https://doi.org/10.15537/smj.2018.5.22641CrossRefPubMedPubMedCentral

26.

Mirzaei M, Pournamdar Z, Salehiniya H (2015) Epidemiology and trends in incidence of kidney cancer in Iran. Asian Pac J Cancer Prev 16(14):5859–5861. https://doi.org/10.7314/apjcp.2015.16.14.5859CrossRefPubMed

27.

Saad AM, Gad MM, Al-Husseini MJ, Ruhban IA, Sonbol MB, Ho TH (2019) Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-Based Study. Clin Genitourin Cancer 17(1):46-57.e5. https://doi.org/10.1016/j.clgc.2018.10.002CrossRefPubMed

28.

Luke C, Sargent N, Pittman K, Price T, Roder D (2011) Epidemiology of cancers of the kidney in an Australian population. Asian Pac J Cancer Prev 12(11):2893–2899PubMed

29.

Scelo G, Li P, Chanudet E, Muller DC (2018) Variability of sex disparities in cancer incidence over 30 years: the striking case of kidney cancer. Eur Urol Focus. https://doi.org/10.1016/j.euf.2017.01.006CrossRefPubMed

30.

Levi F et al (2008) The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 101(8):949–958. https://doi.org/10.1111/j.1464-410X.2008.07451.xCrossRefPubMed

31.

Wong MCS et al (2017) Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries. Sci Rep 7(1):15698. https://doi.org/10.1038/s41598-017-15922-4CrossRefPubMedPubMedCentral

32.

Alkhateeb SS, Alkhateeb JM, Alrashidi EA (2015) Increasing trends in kidney cancer over the last 2 decades in Saudi Arabia. Saudi Med J 36(6):698–703. https://doi.org/10.15537/smj.2015.6.10841CrossRefPubMedPubMedCentral

33.

Espey DK et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152. https://doi.org/10.1002/cncr.23044CrossRefPubMed

34.

Li J, Weir HK, Jim MA, King SM, Wilson R, Master VA (2014) Kidney cancer incidence and mortality among American Indians and Alaska Natives in the United States, 1990–2009. Am J Public Health 104(Suppl 3):S396–S403. https://doi.org/10.2105/AJPH.2013.301616CrossRefPubMedPubMedCentral

35.

Li P et al (2015) Regional geographic variations in kidney cancer incidence rates in European countries. Eur Urol 67(6):1134–1141. https://doi.org/10.1016/j.eururo.2014.11.001CrossRefPubMed

36.

Azawi NH, Joergensen SM, Jensen NV, Clark PE, Lund L, Academy of Geriatric Cancer Research (AgeCare) (2016) Trends in kidney cancer among the elderly in Denmark, 1980–2012. Acta Oncol. https://doi.org/10.3109/0284186X.2015.1115121CrossRef

37.

Capitanio U et al (2019) Epidemiology of renal cell carcinoma. Eur Urol 75(1):74–84. https://doi.org/10.1016/j.eururo.2018.08.036CrossRefPubMed

38.

Decastro GJ, McKiernan JM (2008) Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin N Am. https://doi.org/10.1016/j.ucl.2008.07.005CrossRef

39.

Linehan JA, Nguyen MM (2009) Kidney cancer: the new landscape. Curr Opin Urol 19(2):133–137. https://doi.org/10.1097/MOU.0b013e328323f5abCrossRefPubMed

40.

Weikert S, Ljungberg B (2010) Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol 28(3):247–252. https://doi.org/10.1007/s00345-010-0555-1CrossRefPubMed

41.

Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA (2019) Systematic review of modifiable risk factors for kidney cancer. Urol Oncol 37(6):359–371. https://doi.org/10.1016/j.urolonc.2018.12.008CrossRefPubMed

42.

Petejova N, Martinek A (2016) Renal cell carcinoma: review of etiology, pathophysiology and risk factors. Biomed Pap 160(2):183–194. https://doi.org/10.5507/bp.2015.050CrossRef

43.

Chow W-H, Dong LM, Devesa SS (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7(5):245–257. https://doi.org/10.1038/nrurol.2010.46CrossRefPubMedPubMedCentral

44.

Everatt R, Virvičiūtė D, Tamošiūnas A (2019) Body mass index and other risk factors for kidney cancer in men: a cohort study in Lithuania. Cent Eur J Public Health 27(4):272–278. https://doi.org/10.21101/cejph.a5080CrossRefPubMed

45.

Sibai AM et al (2016) Cigarette smoking in a Middle Eastern country and its association with hospitalisation use: a nationwide cross-sectional study. BMJ Open 6(4):e009881. https://doi.org/10.1136/bmjopen-2015-009881CrossRefPubMedPubMedCentral

46.

Jawad M, Charide R, Waziry R, Darzi A, Ballout RA, Akl EA (2018) The prevalence and trends of waterpipe tobacco smoking: a systematic review. PloS One 13(2):e0192191. https://doi.org/10.1371/journal.pone.0192191

47.

Chidiac A, Tamim H, Kanso M, Tfayli A (2016) Smoking among Lebanese medical students: prevalence and attitudes. Ann Thorac Med 11(3):183. https://doi.org/10.4103/1817-1737.185757CrossRefPubMedPubMedCentral

48.

Musaiger AO (2011) Overweight and obesity in Eastern Mediterranean region: prevalence and possible causes. J Obes 2011:407237. https://doi.org/10.1155/2011/407237CrossRefPubMedPubMedCentral

49.

Nasreddine L, Naja F, Chamieh MC, Adra N, Sibai A-M, Hwalla N (2012) Trends in overweight and obesity in Lebanon: evidence from two national cross-sectional surveys (1997 and 2009). BMC Public Health 12:798. https://doi.org/10.1186/1471-2458-12-798CrossRefPubMedPubMedCentral

50.

Chamieh MC, Moore HJ, Summerbell C, Tamim H, Sibai AM, Hwalla N (2015) Diet, physical activity and socio-economic disparities of obesity in Lebanese adults: findings from a national study. BMC Public Health. https://doi.org/10.1186/s12889-015-1605-9CrossRefPubMedPubMedCentral

51.

Tahbaz R, Schmid M, Merseburger AS (2018) Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol 28(1):62–79. https://doi.org/10.1097/MOU.0000000000000454CrossRefPubMed

52.

Gray RE, Harris GT (2019) Renal cell carcinoma: diagnosis and management. Am Fam Physician 99(3):179–184. Erratum in: Am Fam Physician. 2019 Jun 15;99(12):732

Title: Kidney cancer trends and risk factors in Lebanon: a 12-year epidemiological study
Authors: Elise Assouad
Said El Hage
Steven Safi
Antonio El Kareh
Elie Mokled
Pascale Salameh
Publication date: 01-02-2022
Publisher: Springer International Publishing
Keywords: Kidney Cancer
Kidney Cancer
Kidney Cancer
Published in: Cancer Causes & Control / Issue 2/2022
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-021-01525-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2022

Validity of breast cancer surgery treatment information in a state-based cancer registry

Dietary patterns in adolescence and risk of colorectal cancer: a population-based study

Socioeconomic inequalities in colorectal cancer incidence in Canada: trends over two decades

Reliability of baseline self-reported information in the AGRICAN cohort

The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis

Alcohol intake and risk of pituitary adenoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer